CEP135
protein-codingcentrosomal protein 135
Gene summary
This gene encodes a centrosomal protein, which acts as a scaffolding protein during early centriole biogenesis, and is also required for centriole-centriole cohesion during interphase. Mutations in this gene are associated with autosomal recessive primary microcephaly-8. [provided by RefSeq, Jun 2012]
- KIAA0635
- CEP4
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~84.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013849
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0016660
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013849
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CEP135 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_025009.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 103 | 2 | 109 | ||
| missense | 1 | 233 | 34 | 2 | 270 | |
| nonsense | 13 | 12 | 3 | 28 | ||
| start loss | 0 | |||||
| frameshift | 21 | 10 | 31 | |||
| splice donor/acceptor (+/-2bp) | 1 | 10 | 6 | 17 | ||
| Total | 35 | 33 | 246 | 137 | 4 | 455 |
Highest pathogenic variant AF is 0.00008490732
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_079285.2 | 24 | MANE Select | |
| Ensembl | ENSP00000257287.3 | 24 | MANE Select | |
| Ensembl | ENSP00000412799.2 | 5 | Standard | |
| Ensembl | ENSP00000412799.2 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Regulation of PLK1 Activity at G2/M Transition
- Recruitment of mitotic centrosome proteins and complexes
- Loss of Nlp from mitotic centrosomes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Centrosome maturation
Biological Process
- G2/M transition of mitotic cell cycle
- centriole replication
- regulation of G2/M transition of mitotic cell cycle
- centriole-centriole cohesion
- ciliary basal body-plasma membrane docking
Molecular Function
- protein binding
- protein C-terminus binding
Cellular Component
- centrosome
- centriole
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000257287
- Coding exons
- 24
- Length
- 84493
- Individuals with no LoFs
- 125511
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 237
- Defined
- 125748
- p
- 0.000943
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0804 | 565 | 570 | 0.991 | 0.0000298 | 7475 |
| Missense (PolyPhen) | 175 | 181.33 | 0.96512 | 2513 | ||
| Synonymous | 0.804 | 180 | 194 | 0.927 | 0.00000943 | 2027 |
| Loss of Function | 2.87 | 46 | 72.4 | 0.635 | 0.00000453 | 883 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0037 | 0.0037 | notable |
| Latino/Admixed American | 0.00066 | 0.00058 | rare |
| Ashkenazi Jewish | 0.00040 | 0.00040 | rare |
| East Asian | 0.0020 | 0.0020 | notable |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00073 | 0.00071 | rare |
| South Asian | 0.0010 | 0.00098 | notable |
| Other | 0.00051 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in early centriole assembly/duplication/biogenesis/formation/. Required for centriole elongation. Required for the recruitment of CEP295 to the proximal end of new-born centrioles at the centriolar microtubule wall during early S phase in a PLK4-dependent manner. {ECO:0000269|PubMed:27185865}.;
- Disease
- DISEASE: Microcephaly 8, primary, autosomal recessive (MCPH8) [MIM:614673]: A disease defined as a head circumference more than 3 standard deviations below the age-related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. Despite this marked reduction in size, the gyral pattern is relatively well preserved, with no major abnormality in cortical architecture. Affected individuals are mentally retarded. Primary microcephaly is further defined by the absence of other syndromic features or significant neurological deficits due to degenerative brain disorder. {ECO:0000269|PubMed:22521416}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- LoFtool
- 0.995
- RVIS EVS
- 0.43
- RVIS percentile EVS
- 77.35
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.865
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |